Received Mar 19, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TDAP | TDAP (BOOSTRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | 72NF3 | IM / LA |
The patient reports developing a ?fuzzy? sensation on Thursday (1/29/26) after receiving the Tdap vaccine. On Friday, he experienced increased fatigue, chest discomfort, and elevated blood pressure. According to his Mobile EKG monitor, readings on Friday and Saturday indicated ?possible A-fib.? Since Sunday, he has been in sinus rhythm with overall improvement in symptoms.
None
Cardioversion 9/2025, S/P mitral valve repair 8/2025, Migraines, High cholesterol, Lyme Disease, Hypertension, A-fib
Flax seed daily, Sumatriptan PRN
NA
None